Trevicta 350 mg prolonged release suspension for injection


Prolonged release suspension for injection
scheduling status
S5
registration number
50/2.6.5/0701
What Trevicta 350 mg prolonged release suspension for injection contains
paliperidone palmitate.
other ingredients
Citric acid monohydrate Polyethylene glycol 4000 Polysorbate 20 Sodium dihydrogen phosphate monohydrate Sodium hydroxide (for pH adjustment) Water for injection.
Therapeutic classification
A.2.6.5 Central nervous system depressants.
© 2026 SAHPRA. ALL RIGHTS RESERVED